155 related articles for article (PubMed ID: 12230327)
1. Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis.
Kros JM; Zheng P; Dinjens WN; Alers JC
J Neuropathol Exp Neurol; 2002 Sep; 61(9):806-14. PubMed ID: 12230327
[TBL] [Abstract][Full Text] [Related]
2. Analysis of TP53 and PTEN in gliomatosis cerebri.
Mawrin C; Kirches E; Schneider-Stock R; Scherlach C; Vorwerk C; Von Deimling A; Van Landeghem F; Meyermann R; Bornemann A; Müller A; Romeike B; Stoltenburg-Didinger G; Wickboldt J; Pilz P; Dietzmann K
Acta Neuropathol; 2003 Jun; 105(6):529-36. PubMed ID: 12734658
[TBL] [Abstract][Full Text] [Related]
3. Alterations of cell cycle regulators in gliomatosis cerebri.
Mawrin C; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Mawrin A; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Mawrin A; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Mawrin A; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Deimling A; Stoltenburg-Didinge G; Bornemann A; Romeike B; Sellhaus B; Dietzmann K
J Neurooncol; 2005 Apr; 72(2):115-22. PubMed ID: 15925990
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA as a clonal tumor cell marker: gliomatosis cerebri.
Kirches E; Mawrin C; Schneider-Stock R; Krause G; Scherlach C; Dietzmann K
J Neurooncol; 2003 Jan; 61(1):1-5. PubMed ID: 12587789
[TBL] [Abstract][Full Text] [Related]
5. Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.
Seiz M; Tuettenberg J; Meyer J; Essig M; Schmieder K; Mawrin C; von Deimling A; Hartmann C
Acta Neuropathol; 2010 Aug; 120(2):261-7. PubMed ID: 20514489
[TBL] [Abstract][Full Text] [Related]
6. Gliomatosis cerebri: no evidence for a separate brain tumor entity.
Herrlinger U; Jones DTW; Glas M; Hattingen E; Gramatzki D; Stuplich M; Felsberg J; Bähr O; Gielen GH; Simon M; Wiewrodt D; Schabet M; Hovestadt V; Capper D; Steinbach JP; von Deimling A; Lichter P; Pfister SM; Weller M; Reifenberger G
Acta Neuropathol; 2016 Feb; 131(2):309-319. PubMed ID: 26493382
[TBL] [Abstract][Full Text] [Related]
7. Gliomatosis cerebri: molecular pathology and clinical course.
Herrlinger U; Felsberg J; Küker W; Bornemann A; Plasswilm L; Knobbe CB; Strik H; Wick W; Meyermann R; Dichgans J; Bamberg M; Reifenberger G; Weller M
Ann Neurol; 2002 Oct; 52(4):390-9. PubMed ID: 12325066
[TBL] [Abstract][Full Text] [Related]
8. Distribution of p53 alterations in a case of gliomatosis cerebri.
Mawrin C; Lins H; Kirches E; Schildhaus HU; Scherlach C; Kanakis D; Dietzmann K
Hum Pathol; 2003 Jan; 34(1):102-6. PubMed ID: 12605375
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic alterations in gliomatosis cerebri: what can we learn about the origin and course of the disease?
Mawrin C
Acta Neuropathol; 2005 Dec; 110(6):527-36. PubMed ID: 16222524
[TBL] [Abstract][Full Text] [Related]
10. Gliomatosis cerebri.
Gleizniene R; Bucinskas U; Lukosevicius S; Vaitkus A; Letautiene S; Apanaviciūte D; Galvonaite M
Medicina (Kaunas); 2010; 46(5):341-4. PubMed ID: 20679750
[TBL] [Abstract][Full Text] [Related]
11. Genetic aberrations in gliomatosis cerebri.
Ware ML; Hirose Y; Scheithauer BW; Yeh RF; Mayo MC; Smith JS; Chang S; Cha S; Tihan T; Feuerstein BG
Neurosurgery; 2007 Jan; 60(1):150-8; discussion 158. PubMed ID: 17228264
[TBL] [Abstract][Full Text] [Related]
12. IDH1 mutation, a genetic alteration associated with adult gliomatosis cerebri.
Narasimhaiah D; Miquel C; Verhamme E; Desclée P; Cosnard G; Godfraind C
Neuropathology; 2012 Feb; 32(1):30-7. PubMed ID: 21481010
[TBL] [Abstract][Full Text] [Related]
13. Histological and genetic diagnosis of gliomatosis cerebri: case report.
Yamada SM; Hayashi Y; Takahashi H; Teramoto A; Matsumoto K; Yamada S
J Neurooncol; 2001 May; 52(3):237-40. PubMed ID: 11519853
[TBL] [Abstract][Full Text] [Related]
14. [A case of gliomatosis cerebri in an elderly woman].
Komeno Y; Ako J; Shimada Y; Namba Y; Matsuse T; Toba K; Ouchi Y
Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):540-3. PubMed ID: 11523169
[TBL] [Abstract][Full Text] [Related]
15. Spatial variability of genomic aberrations in a large glioblastoma resection specimen.
Kros JM; van Run PR; Alers JC; Avezaat CJ; Luider TM; van Dekken H
Acta Neuropathol; 2001 Jul; 102(1):103-9. PubMed ID: 11547944
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of molecular genetic alterations associated with tumor progression in a case of gliomatosis cerebri.
Braeuninger S; Schneider-Stock R; Kirches E; Powers JM; Korones DN; Mawrin C
J Neurooncol; 2007 Mar; 82(1):23-7. PubMed ID: 16955219
[TBL] [Abstract][Full Text] [Related]
17. Gliomatosis cerebri: Prognosis based on current molecular markers.
Maharaj MM; Phan K; Xu J; Fairhall J; Reddy R; Rao PJV
J Clin Neurosci; 2017 Sep; 43():1-5. PubMed ID: 28539209
[TBL] [Abstract][Full Text] [Related]
18. Gliomatosis cerebri: neurobehavioral and neuropathological observations.
Filley CM; Kleinschmidt-DeMasters BK; Lillehei KO; Damek DM; Harris JG
Cogn Behav Neurol; 2003 Sep; 16(3):149-59. PubMed ID: 14501536
[TBL] [Abstract][Full Text] [Related]
19. Gliomatosis cerebri in children. Case report and clinical considerations.
Caroli E; Orlando ER; Ferrante L
Childs Nerv Syst; 2005 Nov; 21(11):1000-3. PubMed ID: 16240166
[TBL] [Abstract][Full Text] [Related]
20. Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors.
Fujisawa H; Marukawa K; Hasegawa M; Tohma Y; Hayashi Y; Uchiyama N; Tachibana O; Yamashita J
J Neurosurg; 2002 Dec; 97(6):1350-5. PubMed ID: 12507133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
